| Starts: | Tuesday December 08, 2009 at 8:00am |
|---|---|
| Ends: | Friday December 11, 2009 at 5:00pm |
| Event Type: | Conference |
| Region: | Harrow, United Kingdom |
| Location: |
Royal Garden Hotel 2-24 Kensington High Street London, GREATER LONDON W8 4PT GB |
| Price: | https://secure.terrapinn.com/V5/rCalc.aspx?E=3105 |
| Website: | http://www.healthnetworkcommunications.com/2009/hta |
| Industry: | pharmaceuticals |
| Keywords: | Hta, Market Access, Health Economics, Health Policy, Reimbursement, Pricing, Pharmacoeconomics, Strategy Conference, Outcomes Research, Epidemiology, B2b |
| Intended For: | HTA, market access, health economics, outcomes research, health policy, epidemiology, reimbursement, pricing, pharmacoeconomics |
| Organization: | Health Network Communications |
The first annual Health Technology Assessment World Europe, held in association with the London School of Economics was the most influential meeting on HTA for pharmaceutical products in 2008. Over the course of the 3 days over 100 participants from the world’s leading pharmaceutical and biotechnology product manufacturers plus government agencies, academic institutions, contract service organisations and consultancies attended Health Technology Assessment World.
The 2nd annual policy forum for the industry where all the major HTA agencies across the world and leading pharmaceutical pharmaceutical companies discuss the challenges in obtaining market access.
In 2008 the speaker faculty had an unprecedented 8 health agencies including representatives from NICE, SMC, CAHTAR, CVZ, DIMDI, LFN, Danish Board of Health, BlueCross BlueShield and CADTH. Industry representation came from; Eli Lilly, GlaxoSmithKline, OHE, Bridgehead International and Oxford Outcomes. The meeting covered HTA and Market Access practice in North America, Canada, Europe and Asia and provided a truly global setting for learning, debate and networking.